Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 5686

1.

Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target.

Goyal G, Fan T, Silberstein PT.

Fam Cancer. 2016 Feb 12. [Epub ahead of print]

PMID:
26873719
2.

Update on Lynch syndrome genomics.

Peltomäki P.

Fam Cancer. 2016 Feb 12. [Epub ahead of print]

PMID:
26873718
3.

Lynch Syndrome Screening in the Gynecologic Tract: Current State of the Art.

Mills AM, Longacre TA.

Am J Surg Pathol. 2016 Feb 11. [Epub ahead of print]

PMID:
26872009
4.
5.

Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses.

Haraldsdottir S, Hampel H, Wu C, Weng DY, Shields PG, Frankel WL, Pan X, de la Chapelle A, Goldberg RM, Bekaii-Saab T.

Genet Med. 2016 Feb 11. doi: 10.1038/gim.2015.184. [Epub ahead of print]

PMID:
26866578
6.

Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.

Patel SG, Ahnen DJ, Kinney AY, Horick N, Finkelstein DM, Hill DA, Lindor NM, MaCrae F, Lowery JT.

Am J Gastroenterol. 2016 Feb 9. doi: 10.1038/ajg.2015.397. [Epub ahead of print]

PMID:
26856748
7.

Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies.

Ponti G, Tomasi A, Manfredini M, Pellacani G.

Gene. 2016 Feb 3. pii: S0378-1119(16)30035-X. doi: 10.1016/j.gene.2016.01.053. [Epub ahead of print] Review.

PMID:
26850131
8.

The State of the Art in Colorectal Cancer Molecular Biomarker Testing.

Pillai RK, Lopategui JR, Dhall D, Guindi M, Slavin T, Lofton-Day CE, Patterson SD.

Adv Anat Pathol. 2016 Mar;23(2):92-103. doi: 10.1097/PAP.0000000000000107.

PMID:
26849815
9.

Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.

Kato A, Sato N, Sugawara T, Takahashi K, Kito M, Makino K, Sato T, Shimizu D, Shirasawa H, Miura H, Sato W, Kumazawa Y, Sato A, Kumagai J, Terada Y.

Am J Surg Pathol. 2016 Feb 4. [Epub ahead of print]

PMID:
26848797
10.

Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer.

Soer EC, Leicher LW, Langers AM, van de Meeberg PC, van der Wouden EJ, Koornstra JJ, Bigirwamungu-Bargeman M, Vasen HF, de Vos Tot Nederveen Cappel WH.

Int J Colorectal Dis. 2016 Feb 4. [Epub ahead of print]

PMID:
26847620
11.

Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.

Lin DI, Hecht JL.

Int J Surg Pathol. 2016 Feb 3. pii: 1066896916629782. [Epub ahead of print]

PMID:
26842347
12.

Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.

Kohda M, Kumamoto K, Eguchi H, Hirata T, Tada Y, Tanakaya K, Akagi K, Takenoshita S, Iwama T, Ishida H, Okazaki Y.

Fam Cancer. 2016 Feb 2. [Epub ahead of print]

PMID:
26837502
13.

Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.

Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, Perez Mies B, Soslow RA, Lim RS, Viale A, Huberman KH, Palacios JC, Reis-Filho JS, Matias-Guiu X, Weigelt B.

J Natl Cancer Inst. 2016 Feb 1;108(6). pii: djv427. doi: 10.1093/jnci/djv427. Print 2016 Jun.

PMID:
26832770
14.

HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.

Buhard O, Lagrange A, Guilloux A, Colas C, Chouchène M, Wanherdrick K, Coulet F, Guillerm E, Dorard C, Marisa L, Bokhari A, Greene M, El-Murr N, Bodo S, Muleris M, Sourouille I, Svrcek M, Cervera P, Blanché H, Lefevre JH, Parc Y, Lepage C, Chapusot C, Bouvier AM, Gaub MP, Selves J, Garrett K, Iacopetta B, Soong R, Hamelin R, Garrido C, Lascols O, André T, Fléjou JF, Collura A, Duval A.

J Med Genet. 2016 Feb 1. pii: jmedgenet-2015-103518. doi: 10.1136/jmedgenet-2015-103518. [Epub ahead of print]

PMID:
26831756
15.

Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.

Tanaka M, Nakajima T, Sugano K, Yoshida T, Taniguchi H, Kanemitsu Y, Nagino M, Sekine S.

Histopathology. 2016 Jan 30. doi: 10.1111/his.12941. [Epub ahead of print]

PMID:
26826556
16.

Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.

Jessup CJ, Redston M, Tilton E, Reimann JD.

Hum Pathol. 2016 Mar;49:1-9. doi: 10.1016/j.humpath.2015.10.005. Epub 2015 Oct 31.

PMID:
26826402
17.

Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome.

Frey MK, David-West G, Mittal KR, Muggia FM, Pothuri B.

Ecancermedicalscience. 2016 Jan 18;10:613. doi: 10.3332/ecancer.2016.613. eCollection 2016.

18.

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.

Hall MJ, Obeid EI, Schwartz SC, Mantia-Smaldone G, Forman AD, Daly MB.

Gynecol Oncol. 2016 Jan 23. pii: S0090-8258(16)30016-6. doi: 10.1016/j.ygyno.2016.01.019. [Epub ahead of print] Review.

PMID:
26812021
19.

Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families.

Talseth-Palmer BA, Bauer DC, Sjursen W, Evans TJ, McPhillips M, Proietto A, Otton G, Spigelman AD, Scott RJ.

Cancer Med. 2016 Jan 25. doi: 10.1002/cam4.628. [Epub ahead of print]

20.

Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions.

Vierkoetter KR, Kagami LA, Ahn HJ, Shimizu DM, Terada KY.

Int J Gynecol Cancer. 2016 Feb;26(2):228-32. doi: 10.1097/IGC.0000000000000606.

PMID:
26807560
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk